AcertaPharma

Wrightstown, Wisconsin, United States

650-591-2800 ★

Company profile

AcertaPharma company profile

Acerta Pharma is focused on the development of covalent binding technology solutions to create therapies for cancer. Acerta Pharma was acquired by AstraZeneca in February 2016. Acerta Pharma was founded in 2013 and is based in San Carlos, California.

Business identity

Website: http://www.acerta-pharma.com
Contact email: [email protected]
Phone number: 650-591-2800
Operating status: Active
Company type: For Profit
Employee range: 00051-00100 employees
Revenue range: $100K+
Founded: 2013-01-01

Headquarters

Headquarters: Wrightstown, Wisconsin, United States
Postal code: 94080
Country code: US
Continent: North America

Capital profile

Funding and company signals

Funding stage: M And A
Funding rounds: 1
Total equity funding: $60M
Last funding: Series A / $60M / 2013-03-14
Last equity funding: Series A / $60M
Investors: 3
Lead investors: 1
Founders: 5
Articles: 3
Exited on: 2015-12-17

Categories and groups

Biotechnology Oncology Pharmaceutical Therapeutics Biotechnology Health Care Science and Engineering

Founders and investors

Founders

Ahmed HamdyAllard KapteinFrancisco D. SalvaRaquel IzumiTjeerd Barf

Lead investors

Frazier Healthcare Partners

Investors

BioGeneration VenturesBOMFrazier Healthcare Partners

People at this company

Preview only. Contact details are available after you sign in.

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Shipment records and coverage can change as the dataset is updated.